The DOD invested 33 million dollars in the development of BrainScope One.
BrainScope One was supported by seven research studies from the DoD.
BrainScope One was field-tested by the U.S. Army 82nd Airborne.
The technology is currently being used in 25+ combat divisions, TBI clinics, and military treatment facilities.
BrainScope One is deployed overseas, including Afghanistan, Kuwait, Japan, and Germany.
2019 AMSUS Annual Meeting - December 2-6, 2019, Gaylord National Resort & Convention Center, Oxon Hill, MD
2020 SOFIC (Special Operation Forces Industry Conference) - May 11-14, 2020, Tampa Convention Center, Tampa, FL